Allergan, Inc. (AGN) Tops Q2 EPS by 1c; Guides Q3, Raises FY11 Outlook
Tweet
Share
E-mailGet Alerts AGN Hot Sheet
Price: $193.02 --0%
Financial Fact:
Basic (in dollars per share): 1.05
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Basic (in dollars per share): 1.05
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Allergan, Inc. (NYSE: AGN) reported Q2 EPS of $0.96, $0.01 better than the analyst estimate of $0.95. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.34 billion.
Sees Q3 2011 EPS of $0.88-$0.90, versus the consensus of $0.91.
Sees FY2011 EPS of $3.59-$3.63, versus prior guidance of $3.56-$3.62 and the consensus of $3.64. Sees FY2011 revenue of $5.22-$5.37 billion, versus prior guidance of $5.05-$5.25 billion and the consensus of $5.31 billion.
Sees Q3 2011 EPS of $0.88-$0.90, versus the consensus of $0.91.
Sees FY2011 EPS of $3.59-$3.63, versus prior guidance of $3.56-$3.62 and the consensus of $3.64. Sees FY2011 revenue of $5.22-$5.37 billion, versus prior guidance of $5.05-$5.25 billion and the consensus of $5.31 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
- Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77
- Nomad Foods Limited (NOMD) Tops Q2 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
